Neusignal Therapeutics, a startup spun off from Tohoku University, announced on January 31st that it has raised a total of 2.25 billion yen in a Series A round. The funding includes a 1.1 billion ...
The leveraged finance and private equity communities came together on 29 January 2025 for the inaugural Leveraged Finance Fights Melanoma (LFFM) London benefit ...
Sumitomo Chemical Company, Limited ( OTCPK:SOMMY) Q3 2025 Results Conference Call February 3, 2025 3:00 AM ET Takato Watabe - Morgan Stanley MUFG Securities Makio Yamada - Mizuho Securities Go ...
The major U.S. index futures are currently pointing to a sharply lower open on Monday, with stocks likely to extend the pullback seen ...
Equities research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Schrödinger in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar ...
In November, Sumitomo Mitsui Financial Group (SMFG ... Chimerix’s (CMRX) novel drug, Dordaviprone- which holds the potential to treat patients with H3 K27M-mutant diffuse glioma- is currently ...
Tokyo, Jan. 29 (Jiji Press)--Japanese megabank group Sumitomo Mitsui Financial Group Inc. said Wednesday that it has named Makoto Takashima, chairman of core unit Sumitomo Mitsui Banking Corp., as ...
Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...
SMFG India Credit has launched its new brand film that tells a compelling story of hope, transformation, and limitless ...
TOKYO -- Sumitomo Mitsui Banking Corp. has launched asset-based financing that uses semiconductor manufacturing equipment as collateral, providing another avenue to help meet the industry's ...
Lim Rui Wen, an analyst from DBS, maintained the Buy rating on Sumitomo Mitsui Financial Group (SMFNF – Research Report). The associated price target remains the same with Yen4,100.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results